{"id": "IEPA.d4.s7_IEPA.d4.s7.p0", "text": "The action of PGF2 alpha depends on extracellular Ca2+, whereas oxytocin activates the G-protein-dependent phospholipase-C-IP3-Ca2+ signal-transducing pathway, complemented by the influx of extracellular Ca2+", "text_with_entity_marker": "The action of PGF2 alpha depends on extracellular Ca2+, whereas [E1]oxytocin[/E1] activates the G-protein-dependent phospholipase-C-[E2]IP3[/E2]-Ca2+ signal-transducing pathway, complemented by the influx of extracellular Ca2+", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d5.s8_IEPA.d5.s8.p0", "text": "Oxytocin-stimulated inositol phosphate turnover in endometrium of ewes is influenced by stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins", "text_with_entity_marker": "[E1]Oxytocin[/E1]-stimulated [E2]inositol phosphate[/E2] turnover in endometrium of ewes is influenced by stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphate", "entity_2_idx": [[20, 38]], "entity_2_idx_in_text_with_entity_marker": [33, 51], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d8.s14_IEPA.d8.s14.p0", "text": "The objectives of this study were to evaluate and compare the actions of endothelin-1 (ET-1), oxytocin, prostaglandin F2 alpha (PGF2 alpha) and inositol 1,4,5-trisphosphate (IP3) on 45Ca2+ mobilization in permeabilized rat myometrial cells and to examine the activation of the inositol lipid cycle in intact myocytes", "text_with_entity_marker": "The objectives of this study were to evaluate and compare the actions of endothelin-1 (ET-1), [E1]oxytocin[/E1], prostaglandin F2 alpha (PGF2 alpha) and [E2]inositol 1,4,5-trisphosphate[/E2] (IP3) on 45Ca2+ mobilization in permeabilized rat myometrial cells and to examine the activation of the inositol lipid cycle in intact myocytes", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol 1,4,5-trisphosphate", "entity_2_idx": [[144, 172]], "entity_2_idx_in_text_with_entity_marker": [157, 185], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d16.s33_IEPA.d16.s33.p0", "text": "They are needed for the catabolism of cholesterol, bile acids, and steroid hormones; they hydrolyze a number of flavonoid glycosides to anticarcinogens; and they detoxify certain carcinogens", "text_with_entity_marker": "They are needed for the catabolism of [E1]cholesterol[/E1], bile acids, and steroid hormones; they hydrolyze a number of [E2]flavonoid[/E2] glycosides to anticarcinogens; and they detoxify certain carcinogens", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cholesterol", "entity_1_idx": [[38, 49]], "entity_1_idx_in_text_with_entity_marker": [42, 53], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "flavonoid", "entity_2_idx": [[112, 121]], "entity_2_idx_in_text_with_entity_marker": [125, 134], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d20.s43_IEPA.d20.s43.p2", "text": "Endometrial IP3 was increased within 30 seconds after OT treatment and preceded the increase in PGF2 alpha release stimulated by OT", "text_with_entity_marker": "Endometrial IP3 was increased within 30 seconds after [E1]OT[/E1] treatment and preceded the increase in PGF2 alpha release stimulated by [E2]OT[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[54, 56]], "entity_1_idx_in_text_with_entity_marker": [58, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[129, 131]], "entity_2_idx_in_text_with_entity_marker": [142, 144], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d20.s44_IEPA.d20.s44.p0", "text": "These results support the hypothesis that OT stimulates phospholipase C to hydrolyze PI, yielding IP3 and DAG second-messengers which promote endometrial PGF2 alpha release during CL regression in pigs", "text_with_entity_marker": "These results support the hypothesis that [E1]OT[/E1] stimulates phospholipase C to hydrolyze PI, yielding [E2]IP3[/E2] and DAG second-messengers which promote endometrial PGF2 alpha release during CL regression in pigs", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p5", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular [E1]prion protein[/E1] isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a [E2]prion protein[/E2]-specific kinase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[193, 206]], "entity_1_idx_in_text_with_entity_marker": [197, 210], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "prion protein", "entity_2_idx": [[423, 436]], "entity_2_idx_in_text_with_entity_marker": [436, 449], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d23.s47_IEPA.d23.s47.p1", "text": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.", "text_with_entity_marker": "The resulting abnormally phosphorylated [E1]PrPsc[/E1] aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a [E2]prion protein[/E2]-specific protein kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PrPsc", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "prion protein", "entity_2_idx": [[203, 216]], "entity_2_idx_in_text_with_entity_marker": [216, 229], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s50_IEPA.d24.s50.p0", "text": "Two nanograms oxytocin given ICV had no effect on glucagon and glucose levels but caused a significant rise in insulin levels at this time point", "text_with_entity_marker": "Two nanograms [E1]oxytocin[/E1] given ICV had no effect on glucagon and glucose levels but caused a significant rise in [E2]insulin[/E2] levels at this time point", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[14, 22]], "entity_1_idx_in_text_with_entity_marker": [18, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s51_IEPA.d24.s51.p3", "text": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate", "text_with_entity_marker": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased [E1]insulin[/E1] levels itself and therefore the effect on [E2]oxytocin[/E2]-induced insulin secretion was difficult to evaluate", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[96, 103]], "entity_1_idx_in_text_with_entity_marker": [100, 107], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[146, 154]], "entity_2_idx_in_text_with_entity_marker": [159, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d27.s57_IEPA.d27.s57.p0", "text": "8-OH-DPAT also increased insulin and decreased CCK and somatostatin levels, effects that were blocked by pretreatment with the oxytocin antagonist", "text_with_entity_marker": "8-OH-DPAT also increased [E1]insulin[/E1] and decreased CCK and somatostatin levels, effects that were blocked by pretreatment with the [E2]oxytocin[/E2] antagonist", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[25, 32]], "entity_1_idx_in_text_with_entity_marker": [29, 36], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d29.s61_IEPA.d29.s61.p0", "text": "This action of beta-amyloid 25-35 is not altered by pretreatment with the calcium channel blockers nifedipine or cobalt, with the depleter of intracellular calcium stores cyclopiazonic acid, or with the phospholipase C inhibitor neomycin", "text_with_entity_marker": "This action of [E1]beta-amyloid[/E1] 25-35 is not altered by pretreatment with the calcium channel blockers nifedipine or cobalt, with the depleter of intracellular calcium stores cyclopiazonic acid, or with the [E2]phospholipase C[/E2] inhibitor neomycin", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-amyloid", "entity_1_idx": [[15, 27]], "entity_1_idx_in_text_with_entity_marker": [19, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[203, 218]], "entity_2_idx_in_text_with_entity_marker": [216, 231], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s72_IEPA.d33.s72.p2", "text": "OBJECTIVE: In order to elucidate the roles of inositol trisphosphate (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of IP3 induced by OT and the OT receptor levels were determined in rabbit myometria before and after parturition", "text_with_entity_marker": "OBJECTIVE: In order to elucidate the roles of inositol trisphosphate (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of [E1]IP3[/E1] induced by [E2]OT[/E2] and the OT receptor levels were determined in rabbit myometria before and after parturition", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IP3", "entity_1_idx": [[147, 150]], "entity_1_idx_in_text_with_entity_marker": [151, 154], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[162, 164]], "entity_2_idx_in_text_with_entity_marker": [175, 177], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s73_IEPA.d33.s73.p0", "text": "METHODS: The effects of OT on IP3 formation and OT receptor levels were determined in the myometria of non-pregnant rabbits, Days 26, 28 and 30 of pregnancy rabbits, postpartum rabbits within 12 hours and steroid-treated ovariectomized rabbits", "text_with_entity_marker": "METHODS: The effects of [E1]OT[/E1] on [E2]IP3[/E2] formation and OT receptor levels were determined in the myometria of non-pregnant rabbits, Days 26, 28 and 30 of pregnancy rabbits, postpartum rabbits within 12 hours and steroid-treated ovariectomized rabbits", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[24, 26]], "entity_1_idx_in_text_with_entity_marker": [28, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[30, 33]], "entity_2_idx_in_text_with_entity_marker": [43, 46], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s74_IEPA.d33.s74.p0", "text": "RESULTS: OT receptors were not detectable in the myometria of non-pregnant rabbits, and OT had no effect on the formation of inositol phosphates (IPs)", "text_with_entity_marker": "RESULTS: OT receptors were not detectable in the myometria of non-pregnant rabbits, and [E1]OT[/E1] had no effect on the formation of [E2]inositol phosphates[/E2] (IPs)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[88, 90]], "entity_1_idx_in_text_with_entity_marker": [92, 94], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphates", "entity_2_idx": [[125, 144]], "entity_2_idx_in_text_with_entity_marker": [138, 157], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s78_IEPA.d33.s78.p0", "text": "In addition, an OT receptor antagonist inhibited the stimulatory effects of OT on IP3 formation", "text_with_entity_marker": "In addition, an OT receptor antagonist inhibited the stimulatory effects of [E1]OT[/E1] on [E2]IP3[/E2] formation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[76, 78]], "entity_1_idx_in_text_with_entity_marker": [80, 82], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s89_IEPA.d36.s89.p0", "text": "The antilipolytic effects of peroxovanadate and oxytocin were unaffected by 500 nmol/L wortmannin, which blocked the antilipolytic action of insulin", "text_with_entity_marker": "The antilipolytic effects of peroxovanadate and [E1]oxytocin[/E1] were unaffected by 500 nmol/L wortmannin, which blocked the antilipolytic action of [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[141, 148]], "entity_2_idx_in_text_with_entity_marker": [154, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s98_IEPA.d40.s98.p0", "text": "MPA markedly inhibited PLC in both conditions; however, insulin secretion was only inhibited (by 46%) in primed islets", "text_with_entity_marker": "MPA markedly inhibited [E1]PLC[/E1] in both conditions; however, [E2]insulin[/E2] secretion was only inhibited (by 46%) in primed islets", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d41.s102_IEPA.d41.s102.p0", "text": "The inability to activate a nutrient- and calcium-regulated phospholipase C isozyme in mouse islets to the same extent as in rat islets appears to account, at least in part, for these different insulin secretory responses under these unique conditions", "text_with_entity_marker": "The inability to activate a nutrient- and calcium-regulated [E1]phospholipase C[/E1] isozyme in mouse islets to the same extent as in rat islets appears to account, at least in part, for these different [E2]insulin[/E2] secretory responses under these unique conditions", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[60, 75]], "entity_1_idx_in_text_with_entity_marker": [64, 79], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[194, 201]], "entity_2_idx_in_text_with_entity_marker": [207, 214], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d42.s105_IEPA.d42.s105.p0", "text": "When rat islet are cultured for short periods, the content and activation of PLC in response to glucose decreases and this biochemical defect in signal transduction is paralleled by significant reductions in glucose-induced insulin secretion", "text_with_entity_marker": "When rat islet are cultured for short periods, the content and activation of [E1]PLC[/E1] in response to glucose decreases and this biochemical defect in signal transduction is paralleled by significant reductions in glucose-induced [E2]insulin[/E2] secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[224, 231]], "entity_2_idx_in_text_with_entity_marker": [237, 244], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d44.s112_IEPA.d44.s112.p0", "text": "Further, the oxytocin-induced activation of IK(sl) was effectively antagonized by 5 x 10(-8) mol/l U-73122 or 5 x 10(-6) mol/l 2-nitro-4-carboxyphenyl N,N-diphenylcarbamate (inhibitors of the cell membrane phospholipase C), as well as by intracellularly applied heparin (selective inhibitor of inositol-1,4,5-trisphosphate (IP3)-induced Ca2+ release channels)", "text_with_entity_marker": "Further, the [E1]oxytocin[/E1]-induced activation of IK(sl) was effectively antagonized by 5 x 10(-8) mol/l U-73122 or 5 x 10(-6) mol/l 2-nitro-4-carboxyphenyl N,N-diphenylcarbamate (inhibitors of the cell membrane phospholipase C), as well as by intracellularly applied heparin (selective inhibitor of [E2]inositol-1,4,5-trisphosphate[/E2] (IP3)-induced Ca2+ release channels)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol-1,4,5-trisphosphate", "entity_2_idx": [[294, 322]], "entity_2_idx_in_text_with_entity_marker": [307, 335], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s115_IEPA.d46.s115.p0", "text": "Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein (25-35) stimulation of [E2]phospholipase C[/E2] in LA-N-2 cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[44, 59]], "entity_2_idx_in_text_with_entity_marker": [57, 72], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s122_IEPA.d47.s122.p1", "text": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT", "text_with_entity_marker": "The maximal [E1]insulin[/E1] responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma [E2]insulin[/E2] were higher than those of OT", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[12, 19]], "entity_1_idx_in_text_with_entity_marker": [16, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s124_IEPA.d48.s124.p0", "text": "Leptin increased BAT UCP mRNA levels greater than twofold in both ad libitum-fed and food-restricted rats", "text_with_entity_marker": "[E1]Leptin[/E1] increased BAT [E2]UCP[/E2] mRNA levels greater than twofold in both ad libitum-fed and food-restricted rats", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[21, 24]], "entity_2_idx_in_text_with_entity_marker": [34, 37], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s125_IEPA.d48.s125.p2", "text": "These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP", "text_with_entity_marker": "These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which [E1]leptin[/E1] increases energy expenditure is through increased thermogenesis in BAT, including increased expression of [E2]UCP[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[132, 138]], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[245, 248]], "entity_2_idx_in_text_with_entity_marker": [258, 261], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s130_IEPA.d50.s130.p0", "text": "This action of leptin on PLC-mediated insulin secretion was dose-dependent, rapid-onset (i.e., within 3 min), and reversible", "text_with_entity_marker": "This action of leptin on [E1]PLC[/E1]-mediated [E2]insulin[/E2] secretion was dose-dependent, rapid-onset (i.e., within 3 min), and reversible", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[38, 45]], "entity_2_idx_in_text_with_entity_marker": [51, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d51.s134_IEPA.d51.s134.p0", "text": "The hydrophilic form of MDP released from the cells on stimulation with insulin was recognized by antibodies against the inositol 1,2-cyclic monophosphate cross-reacting determinant, indicating that it had been generated by cleavage of its GPI anchor through the action of a phospholipase C", "text_with_entity_marker": "The hydrophilic form of MDP released from the cells on stimulation with [E1]insulin[/E1] was recognized by antibodies against the inositol 1,2-cyclic monophosphate cross-reacting determinant, indicating that it had been generated by cleavage of its GPI anchor through the action of a [E2]phospholipase C[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[275, 290]], "entity_2_idx_in_text_with_entity_marker": [288, 303], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d55.s140_IEPA.d55.s140.p0", "text": "The effect of AVP was also inhibited in the presence of the protein kinase C inhibitor calphostin C", "text_with_entity_marker": "The effect of [E1]AVP[/E1] was also inhibited in the presence of the [E2]protein kinase C[/E2] inhibitor calphostin C", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[60, 76]], "entity_2_idx_in_text_with_entity_marker": [73, 89], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d68.s169_IEPA.d68.s169.p0", "text": "The results demonstrate that potent antioxidants, such as flavonoids, protect MM-LDL from lipoperoxidation and preserve their ability to efficiently deliver cholesterol to cells", "text_with_entity_marker": "The results demonstrate that potent antioxidants, such as [E1]flavonoids[/E1], protect MM-LDL from lipoperoxidation and preserve their ability to efficiently deliver [E2]cholesterol[/E2] to cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "flavonoids", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[157, 168]], "entity_2_idx_in_text_with_entity_marker": [170, 181], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d73.s174_IEPA.d73.s174.p0", "text": "Furthermore, treatment of isolated rat diaphragms and adipocytes with PIG-P as well as with other agents exerting partially insulin-mimetic activity, such as PI-specific phospholipase C (PLC) and the sulfonylurea glimepiride, triggered tyrosine phosphorylation of the caveolar marker protein caveolin, which was apparently correlated with stimulation of lipogenesis", "text_with_entity_marker": "Furthermore, treatment of isolated rat diaphragms and adipocytes with PIG-P as well as with other agents exerting partially [E1]insulin[/E1]-mimetic activity, such as PI-specific [E2]phospholipase C[/E2] (PLC) and the sulfonylurea glimepiride, triggered tyrosine phosphorylation of the caveolar marker protein caveolin, which was apparently correlated with stimulation of lipogenesis", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[124, 131]], "entity_1_idx_in_text_with_entity_marker": [128, 135], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[170, 185]], "entity_2_idx_in_text_with_entity_marker": [183, 198], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d75.s179_IEPA.d75.s179.p0", "text": "Concurrent decrease of vasopressin and protein kinase Calpha immunoreactivity during the light phase in the vole suprachiasmatic nucleus", "text_with_entity_marker": "Concurrent decrease of [E1]vasopressin[/E1] and [E2]protein kinase Calpha[/E2] immunoreactivity during the light phase in the vole suprachiasmatic nucleus", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vasopressin", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase Calpha", "entity_2_idx": [[39, 60]], "entity_2_idx_in_text_with_entity_marker": [52, 73], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s202_IEPA.d84.s202.p0", "text": "Blood samples for OT assay were taken just before the rapid injection of insulin (time 0) and at time 15, 30, 45 and 60 min", "text_with_entity_marker": "Blood samples for [E1]OT[/E1] assay were taken just before the rapid injection of [E2]insulin[/E2] (time 0) and at time 15, 30, 45 and 60 min", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[18, 20]], "entity_1_idx_in_text_with_entity_marker": [22, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[73, 80]], "entity_2_idx_in_text_with_entity_marker": [86, 93], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s208_IEPA.d88.s208.p0", "text": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "text_with_entity_marker": "These results clearly demonstrate that [E1]UCP3[/E1] gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with [E2]leptin[/E2] receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s208_IEPA.d88.s208.p2", "text": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "text_with_entity_marker": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with [E1]leptin[/E1] receptor defect, and that adipose [E2]UCP3[/E2] gene expression is increased in response to TZDs in vitro", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[144, 150]], "entity_1_idx_in_text_with_entity_marker": [148, 154], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s209_IEPA.d89.s209.p1", "text": "UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin", "text_with_entity_marker": "[E1]UCP2[/E1], UCP3 and [E2]leptin[/E2] gene expression: modulation by food restriction and leptin", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[15, 21]], "entity_2_idx_in_text_with_entity_marker": [28, 34], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s212_IEPA.d89.s212.p1", "text": "The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "text_with_entity_marker": "The present study indicates that [E1]leptin[/E1] increases the gene expression of UCP2 in EWAT and that of [E2]UCP1[/E2], UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[33, 39]], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP1", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s212_IEPA.d89.s212.p4", "text": "The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "text_with_entity_marker": "The present study indicates that leptin increases the gene expression of [E1]UCP2[/E1] in EWAT and that of UCP1, [E2]UCP3[/E2] and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s218_IEPA.d91.s218.p1", "text": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "text_with_entity_marker": "U-73122 at 8 mumol.L-1 totally abolished the [E1]Oxy[/E1]-induced increases in [Ca2+]i and IP3; however it reduced the [E2]Oxy[/E2]-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Oxy", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Oxy", "entity_2_idx": [[110, 113]], "entity_2_idx_in_text_with_entity_marker": [123, 126], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s231_IEPA.d96.s231.p2", "text": "Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment", "text_with_entity_marker": "Downregulation of uncoupling protein 2 mRNA in white adipose tissue and [E1]uncoupling protein 3[/E1] mRNA in skeletal muscle during the early stages of [E2]leptin[/E2] treatment", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "uncoupling protein 3", "entity_1_idx": [[72, 92]], "entity_1_idx_in_text_with_entity_marker": [76, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d97.s235_IEPA.d97.s235.p0", "text": "CONCLUSION: PTH, AVP, PGE2, and adenosine stimulate Ca2+ reabsorption via a pathway that is independent of cAMP and that involves a phorbol ester-insensitive PKC isotype", "text_with_entity_marker": "CONCLUSION: PTH, [E1]AVP[/E1], PGE2, and adenosine stimulate Ca2+ reabsorption via a pathway that is independent of cAMP and that involves a phorbol ester-insensitive [E2]PKC[/E2] isotype", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[158, 161]], "entity_2_idx_in_text_with_entity_marker": [171, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d100.s239_IEPA.d100.s239.p0", "text": "If daily oxytocin injections are repeated over a 5-day period, blood pressure is decreased by 10-20 mmHg, the withdrawal latency to heat stimuli is prolonged, cortisol levels are decreased and insulin and cholecystokinin levels are increased", "text_with_entity_marker": "If daily [E1]oxytocin[/E1] injections are repeated over a 5-day period, blood pressure is decreased by 10-20 mmHg, the withdrawal latency to heat stimuli is prolonged, cortisol levels are decreased and [E2]insulin[/E2] and cholecystokinin levels are increased", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d106.s245_IEPA.d106.s245.p0", "text": "Protein kinase C (PKC) inhibitors reversed AVP inhibition, whereas PKC activator inhibited nitrite production", "text_with_entity_marker": "[E1]Protein kinase C[/E1] (PKC) inhibitors reversed [E2]AVP[/E2] inhibition, whereas PKC activator inhibited nitrite production", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Protein kinase C", "entity_1_idx": [[0, 16]], "entity_1_idx_in_text_with_entity_marker": [4, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[43, 46]], "entity_2_idx_in_text_with_entity_marker": [56, 59], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s253_IEPA.d108.s253.p1", "text": "In addition, both insulin and CCK levels were decreased in response to the oxytocin treatment when measured 3 and 10 days after the last injection (ANOVA; insulin p < 0.01, CCK p < 0.05)", "text_with_entity_marker": "In addition, both [E1]insulin[/E1] and CCK levels were decreased in response to the oxytocin treatment when measured 3 and 10 days after the last injection (ANOVA; [E2]insulin[/E2] p < 0.01, CCK p < 0.05)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[18, 25]], "entity_1_idx_in_text_with_entity_marker": [22, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[155, 162]], "entity_2_idx_in_text_with_entity_marker": [168, 175], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s258_IEPA.d109.s258.p1", "text": "Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "text_with_entity_marker": "[E1]Leptin[/E1], compared with vehicle, did not alter BAT UCP-1 or [E2]UCP-3[/E2] mRNA or protein expression when administered to normal ad libitum fed rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d110.s264_IEPA.d110.s264.p0", "text": "Signal transduction of arginine vasopressin-induced arachidonic acid release in H9c2 cardiac myoblasts: role of Ca2+ and the protein kinase C-dependent activation of p42 mitogen-activated protein kinase", "text_with_entity_marker": "Signal transduction of [E1]arginine vasopressin[/E1]-induced arachidonic acid release in H9c2 cardiac myoblasts: role of Ca2+ and the [E2]protein kinase C[/E2]-dependent activation of p42 mitogen-activated protein kinase", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "arginine vasopressin", "entity_1_idx": [[23, 43]], "entity_1_idx_in_text_with_entity_marker": [27, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[125, 141]], "entity_2_idx_in_text_with_entity_marker": [138, 154], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d110.s266_IEPA.d110.s266.p0", "text": "Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; PKC inhibitors (staurosporine or Ro 31-8220) or down-regulation of PKCalpha, betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the AVP-induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms", "text_with_entity_marker": "Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; [E1]PKC[/E1] inhibitors (staurosporine or Ro 31-8220) or down-regulation of [E2]PKCalpha[/E2], betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the AVP-induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[98, 101]], "entity_1_idx_in_text_with_entity_marker": [102, 105], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKCalpha", "entity_2_idx": [[165, 173]], "entity_2_idx_in_text_with_entity_marker": [178, 186], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s274_IEPA.d114.s274.p0", "text": "In normal pancreatic islets, UCP-2 is upregulated by leptin and is low in leptin-resistant islets of ZDF rats", "text_with_entity_marker": "In normal pancreatic islets, [E1]UCP-2[/E1] is upregulated by [E2]leptin[/E2] and is low in leptin-resistant islets of ZDF rats", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[53, 59]], "entity_2_idx_in_text_with_entity_marker": [66, 72], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s275_IEPA.d114.s275.p3", "text": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "text_with_entity_marker": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in [E1]leptin[/E1]-unresponsive [E2]UCP-2[/E2]-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[148, 154]], "entity_1_idx_in_text_with_entity_marker": [152, 158], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d116.s284_IEPA.d116.s284.p2", "text": "In the present study we found that at increasing GA concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced amylase secretion and vacuolation characteristic of the GA response", "text_with_entity_marker": "In the present study we found that at increasing GA concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced [E1]amylase[/E1] secretion and vacuolation characteristic of the [E2]GA[/E2] response", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "amylase", "entity_1_idx": [[141, 148]], "entity_1_idx_in_text_with_entity_marker": [145, 152], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[197, 199]], "entity_2_idx_in_text_with_entity_marker": [210, 212], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d120.s288_IEPA.d120.s288.p0", "text": "Furthermore, our 14C-acetate-labeling studies showed a 50% reduction in cholesteryl ester synthesis in the presence of either flavonoid, which could account for the reduction in net apoB secretion caused by incubation with these compounds", "text_with_entity_marker": "Furthermore, our 14C-acetate-labeling studies showed a 50% reduction in [E1]cholesteryl ester[/E1] synthesis in the presence of either [E2]flavonoid[/E2], which could account for the reduction in net apoB secretion caused by incubation with these compounds", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cholesteryl ester", "entity_1_idx": [[72, 89]], "entity_1_idx_in_text_with_entity_marker": [76, 93], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "flavonoid", "entity_2_idx": [[126, 135]], "entity_2_idx_in_text_with_entity_marker": [139, 148], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s291_IEPA.d122.s291.p0", "text": "Centrally administered leptin has been shown to increase insulin-stimulated glucose utilization and to favor the expression of uncoupling proteins (UCPs)", "text_with_entity_marker": "Centrally administered [E1]leptin[/E1] has been shown to increase insulin-stimulated glucose utilization and to favor the expression of [E2]uncoupling proteins[/E2] (UCPs)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[23, 29]], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[127, 146]], "entity_2_idx_in_text_with_entity_marker": [140, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p4", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for [E1]UCP1[/E1], 100, 191, and 125 for [E2]UCP2[/E2] and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p6", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for [E1]UCP1[/E1], 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s295_IEPA.d122.s295.p0", "text": "These results suggest that the overall effect of leptin on glucose utilization and on the expression of UCPs may be mediated through central mechanism", "text_with_entity_marker": "These results suggest that the overall effect of [E1]leptin[/E1] on glucose utilization and on the expression of [E2]UCPs[/E2] may be mediated through central mechanism", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCPs", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d123.s296_IEPA.d123.s296.p0", "text": "The activity of catalase was found to be significantly enhanced in the tissues of normal and cholesterol fed rats administered 1 mg flavonoid from brinjal/100 g BW/day", "text_with_entity_marker": "The activity of catalase was found to be significantly enhanced in the tissues of normal and [E1]cholesterol[/E1] fed rats administered 1 mg [E2]flavonoid[/E2] from brinjal/100 g BW/day", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cholesterol", "entity_1_idx": [[93, 104]], "entity_1_idx_in_text_with_entity_marker": [97, 108], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "flavonoid", "entity_2_idx": [[132, 141]], "entity_2_idx_in_text_with_entity_marker": [145, 154], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d124.s297_IEPA.d124.s297.p1", "text": "By comparison with the promoters of alpha-amylase genes, which are also induced by GA, we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a GA response complex", "text_with_entity_marker": "By comparison with the promoters of [E1]alpha-amylase[/E1] genes, which are also induced by GA, we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a [E2]GA[/E2] response complex", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-amylase", "entity_1_idx": [[36, 49]], "entity_1_idx_in_text_with_entity_marker": [40, 53], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[178, 180]], "entity_2_idx_in_text_with_entity_marker": [191, 193], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d125.s298_IEPA.d125.s298.p2", "text": "Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote APP secretion, whereas inhibition of MAP kinase will reduce APP secretion only when phospholipase Cgamma or phosphatidylinositol 3-kinase are additionally inhibited", "text_with_entity_marker": "Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote APP secretion, whereas inhibition of MAP kinase will reduce [E1]APP[/E1] secretion only when [E2]phospholipase Cgamma[/E2] or phosphatidylinositol 3-kinase are additionally inhibited", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APP", "entity_1_idx": [[171, 174]], "entity_1_idx_in_text_with_entity_marker": [175, 178], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma", "entity_2_idx": [[195, 215]], "entity_2_idx_in_text_with_entity_marker": [208, 228], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p6", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and [E1]UCP3[/E1] were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of [E2]leptin[/E2] resulted in induction of the uterine UCP2 and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[208, 214]], "entity_2_idx_in_text_with_entity_marker": [221, 227], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p8", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and [E1]UCP3[/E1] were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and [E2]UCP3[/E2] levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[261, 265]], "entity_2_idx_in_text_with_entity_marker": [274, 278], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d128.s306_IEPA.d128.s306.p0", "text": "Ischemia-reperfusion injury had no effect on Abeta-evoked alterations of synaptic plasma membrane-bound PI-PLC", "text_with_entity_marker": "Ischemia-reperfusion injury had no effect on [E1]Abeta[/E1]-evoked alterations of synaptic plasma membrane-bound [E2]PI-PLC[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Abeta", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[104, 110]], "entity_2_idx_in_text_with_entity_marker": [117, 123], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s309_IEPA.d129.s309.p0", "text": "We examined plasma leptin, leptin mRNA, and adipose and muscle UCP subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system", "text_with_entity_marker": "We examined plasma [E1]leptin[/E1], [E2]leptin[/E2] mRNA, and adipose and muscle UCP subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[19, 25]], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[27, 33]], "entity_2_idx_in_text_with_entity_marker": [40, 46], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s312_IEPA.d130.s312.p0", "text": "Amyloid beta peptide 25-35 modulates hydrolysis of phosphoinositides by membrane phospholipase(s) C of adult brain cortex", "text_with_entity_marker": "[E1]Amyloid[/E1] beta peptide 25-35 modulates hydrolysis of phosphoinositides by membrane [E2]phospholipase(s) C[/E2] of adult brain cortex", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase(s) C", "entity_2_idx": [[81, 99]], "entity_2_idx_in_text_with_entity_marker": [94, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p4", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle [E1]UCP2[/E1] expression, as well as for plasma leptin and WAT [E2]leptin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[383, 387]], "entity_1_idx_in_text_with_entity_marker": [387, 391], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[437, 443]], "entity_2_idx_in_text_with_entity_marker": [450, 456], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d140.s335_IEPA.d140.s335.p0", "text": "Arginine vasopressin (AVP) and lysophosphatidic acid (LPA) have been shown to stimulate protein kinase C (PKC) and mitogen-activated protein (MAP) kinases and the proliferation of vascular smooth muscle cells", "text_with_entity_marker": "[E1]Arginine vasopressin[/E1] (AVP) and lysophosphatidic acid (LPA) have been shown to stimulate [E2]protein kinase C[/E2] (PKC) and mitogen-activated protein (MAP) kinases and the proliferation of vascular smooth muscle cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arginine vasopressin", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[88, 104]], "entity_2_idx_in_text_with_entity_marker": [101, 117], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s355_IEPA.d146.s355.p0", "text": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "text_with_entity_marker": "Pretreatment for 24 h with 1 microM PMA downregulated expression of [E1]PKC-alpha[/E1] and -delta, but not [E2]PKC-epsilon[/E2], and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC-alpha", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC-epsilon", "entity_2_idx": [[98, 109]], "entity_2_idx_in_text_with_entity_marker": [111, 122], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s355_IEPA.d146.s355.p2", "text": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "text_with_entity_marker": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not [E1]PKC-epsilon[/E1], and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM [E2]AVP[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC-epsilon", "entity_1_idx": [[98, 109]], "entity_1_idx_in_text_with_entity_marker": [102, 113], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d150.s364_IEPA.d150.s364.p0", "text": "Leptin has been demonstrated to decrease or down regulate NPY expression and increase POMC expression", "text_with_entity_marker": "[E1]Leptin[/E1] has been demonstrated to decrease or down regulate [E2]NPY[/E2] expression and increase POMC expression", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[58, 61]], "entity_2_idx_in_text_with_entity_marker": [71, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d157.s375_IEPA.d157.s375.p0", "text": "It was shown that, in the absence of exogenous Ca2+, neomycin markedly reduced the germination speed and seedling growth of rice seeds and inhibited the gibberellin-induced expression of alpha-amylase in both secretory tissues", "text_with_entity_marker": "It was shown that, in the absence of exogenous Ca2+, neomycin markedly reduced the germination speed and seedling growth of rice seeds and inhibited the [E1]gibberellin[/E1]-induced expression of [E2]alpha-amylase[/E2] in both secretory tissues", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[153, 164]], "entity_1_idx_in_text_with_entity_marker": [157, 168], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[187, 200]], "entity_2_idx_in_text_with_entity_marker": [200, 213], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d157.s376_IEPA.d157.s376.p0", "text": "These results strongly suggest that the phosphoinositide-Ca2+ signal transduction pathway may play an important role in the gibberellin-induced expression of alpha-amylase molecules closely related to the germination processes of rice seed", "text_with_entity_marker": "These results strongly suggest that the phosphoinositide-Ca2+ signal transduction pathway may play an important role in the [E1]gibberellin[/E1]-induced expression of [E2]alpha-amylase[/E2] molecules closely related to the germination processes of rice seed", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d159.s383_IEPA.d159.s383.p0", "text": "UCP-2 expression remained inversely related with plasma leptin after controlling for percent body (r = -0.45; P = 0.038)", "text_with_entity_marker": "[E1]UCP-2[/E1] expression remained inversely related with plasma [E2]leptin[/E2] after controlling for percent body (r = -0.45; P = 0.038)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[56, 62]], "entity_2_idx_in_text_with_entity_marker": [69, 75], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d160.s385_IEPA.d160.s385.p0", "text": "Thus, highly expressed in human adipocytes, the Y(1) receptor sustains the strong antilipolytic effect of NPY and exerts a positive action on leptin secretion", "text_with_entity_marker": "Thus, highly expressed in human adipocytes, the Y(1) receptor sustains the strong antilipolytic effect of [E1]NPY[/E1] and exerts a positive action on [E2]leptin[/E2] secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[142, 148]], "entity_2_idx_in_text_with_entity_marker": [155, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s387_IEPA.d161.s387.p2", "text": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "text_with_entity_marker": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, [E1]uncoupling protein (UCP)-2[/E1] and [E2]UCP-3[/E2], and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "uncoupling protein (UCP)-2", "entity_1_idx": [[143, 169]], "entity_1_idx_in_text_with_entity_marker": [147, 173], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s388_IEPA.d161.s388.p2", "text": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "text_with_entity_marker": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), [E1]UCP-2[/E1] (120+/-7%; P < 0.05), [E2]UCP-3[/E2] (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[116, 121]], "entity_1_idx_in_text_with_entity_marker": [120, 125], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d173.s419_IEPA.d173.s419.p0", "text": "We have established that the recovery of secreted N1 is increased by the protein kinase C agonists PDBu and PMA in a time- and dose-dependent manner in both cell lines", "text_with_entity_marker": "We have established that the recovery of secreted [E1]N1[/E1] is increased by the [E2]protein kinase C[/E2] agonists PDBu and PMA in a time- and dose-dependent manner in both cell lines", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N1", "entity_1_idx": [[50, 52]], "entity_1_idx_in_text_with_entity_marker": [54, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[73, 89]], "entity_2_idx_in_text_with_entity_marker": [86, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s438_IEPA.d183.s438.p0", "text": "Experimental studies provided evidences that leptin, cholecystokinin (CCK), galanin (GAL), neuropeptide Y (NPY) and insulin are involved in feeding behaviour", "text_with_entity_marker": "Experimental studies provided evidences that [E1]leptin[/E1], cholecystokinin (CCK), galanin (GAL), [E2]neuropeptide Y[/E2] (NPY) and insulin are involved in feeding behaviour", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[45, 51]], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[91, 105]], "entity_2_idx_in_text_with_entity_marker": [104, 118], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s439_IEPA.d183.s439.p0", "text": "Plasma concentrations of FSH, leptin, CCK, GAL, NPY and insulin were determined using commercial RIA kits", "text_with_entity_marker": "Plasma concentrations of FSH, [E1]leptin[/E1], CCK, GAL, [E2]NPY[/E2] and insulin were determined using commercial RIA kits", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s449_IEPA.d187.s449.p0", "text": "GNB suppressed accumulation of GA-induced barley high-pI type B and rice RAmylA alpha-amylase transcripts.", "text_with_entity_marker": "GNB suppressed accumulation of [E1]GA[/E1]-induced barley high-pI type B and rice RAmylA [E2]alpha-amylase[/E2] transcripts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[31, 33]], "entity_1_idx_in_text_with_entity_marker": [35, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[80, 93]], "entity_2_idx_in_text_with_entity_marker": [93, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d189.s453_IEPA.d189.s453.p0", "text": "These findings are consistent with increased leptin signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "text_with_entity_marker": "These findings are consistent with increased [E1]leptin[/E1] signaling to the [E2]NPY[/E2] and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[45, 51]], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[69, 72]], "entity_2_idx_in_text_with_entity_marker": [82, 85], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s461_IEPA.d192.s461.p1", "text": "Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "text_with_entity_marker": "Relative to the wild type, the [E1]GA[/E1](3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a [E2]GA[/E2]-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GA", "entity_1_idx": [[31, 33]], "entity_1_idx_in_text_with_entity_marker": [35, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[156, 158]], "entity_2_idx_in_text_with_entity_marker": [169, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s469_IEPA.d195.s469.p0", "text": "Leptin Rapidly Inhibits Hypothalamic Neuropeptide Y Secretion and Stimulates Corticotropin-Releasing Hormone Secretion in Adrenalectomized Mice", "text_with_entity_marker": "[E1]Leptin[/E1] Rapidly Inhibits Hypothalamic [E2]Neuropeptide Y[/E2] Secretion and Stimulates Corticotropin-Releasing Hormone Secretion in Adrenalectomized Mice", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Neuropeptide Y", "entity_2_idx": [[37, 51]], "entity_2_idx_in_text_with_entity_marker": [50, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s470_IEPA.d195.s470.p0", "text": "Leptin may rapidly inhibit food intake by altering the secretion of hypothalamic neuropeptides such as neuropeptide Y (NPY), a stimulator of food intake, and/or corticotropin-releasing hormone (CRH), an inhibitor of food intake", "text_with_entity_marker": "[E1]Leptin[/E1] may rapidly inhibit food intake by altering the secretion of hypothalamic neuropeptides such as [E2]neuropeptide Y[/E2] (NPY), a stimulator of food intake, and/or corticotropin-releasing hormone (CRH), an inhibitor of food intake", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[103, 117]], "entity_2_idx_in_text_with_entity_marker": [116, 130], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s479_IEPA.d197.s479.p0", "text": "On the basis of far-Western blot and plasmon resonance (BIAcore) experiments, we show here that recombinant bovine prion protein (bPrP) (25-242) strongly interacts with the catalytic alpha/alpha' subunits of protein kinase CK2 (also termed 'casein kinase 2')", "text_with_entity_marker": "On the basis of far-Western blot and plasmon resonance (BIAcore) experiments, we show here that recombinant [E1]bovine prion protein[/E1] (bPrP) (25-242) strongly interacts with the catalytic alpha/alpha' subunits of [E2]protein kinase CK2[/E2] (also termed 'casein kinase 2')", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "bovine prion protein", "entity_1_idx": [[108, 128]], "entity_1_idx_in_text_with_entity_marker": [112, 132], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase CK2", "entity_2_idx": [[208, 226]], "entity_2_idx_in_text_with_entity_marker": [221, 239], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
